According to the latest data from the Stock Exchange of Hong Kong, shareholder Hong Zejun increased his stake in Hepalink (09989) by 4.8155 million shares on January 29, with an average price of HK$5.485 per share, amounting to a total of approximately HK$26.413 million. Following this acquisition, his total shareholding has risen to 20.8155 million shares, representing a latest shareholding ratio of 9.45%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.